Treatment of Lp (a): is it the future or are we ready today?
AD Tselepis - Current Atherosclerosis Reports, 2023 - Springer
Abstract Purpose of Review The goal of this review is to present the pharmacodynamic
effectiveness as well as the clinical efficacy and safety of investigational antisense …
effectiveness as well as the clinical efficacy and safety of investigational antisense …
Lipoprotein (a) and calcific aortic valve disease initiation and progression: a systematic review and meta-analysis
Although evidence indicates the association of lipoprotein (a)[Lp (a)] with atherosclerosis,
the link with calcific aortic valve disease (CAVD) is unclear. This systematic review and meta …
the link with calcific aortic valve disease (CAVD) is unclear. This systematic review and meta …
Lipoprotein (a) As a Potential Predictive Factor for Earlier Aortic Valve Replacement in Patients with Bicuspid Aortic Valve
A Krzesińska, M Nowak, A Mickiewicz, G Chyła-Danił… - Biomedicines, 2023 - mdpi.com
Bicuspid aortic valve (BAV) affects 0.5–2% of the general population and constitutes the
major cause of severe aortic valve stenosis (AVS) in individuals≤ 70 years. The aim of the …
major cause of severe aortic valve stenosis (AVS) in individuals≤ 70 years. The aim of the …
The influence of lipoprotein (a) on aortic valve calcification in patients undergoing transcatheter aortic valve replacement
J Bormann, F Rudolph, M Miller, S Waezsada… - Clinical Research in …, 2024 - Springer
Background Elevated levels of lipoprotein (a)(Lp [a]) have been recognized as substantial
risk factors for cardiovascular disease and aortic stenosis (AS). However, the specific role of …
risk factors for cardiovascular disease and aortic stenosis (AS). However, the specific role of …
Association of lipoprotein (a) with left ventricular hypertrophy assessed by electrocardiogram in adults: a large cross-sectional study
X Yan, J Gong, Z Wang, F Wang, C Qi - Frontiers in Endocrinology, 2023 - frontiersin.org
Background and aims Increasing evidence supports a causal relationship between
lipoprotein (a)[Lp (a)] and atherosclerotic cardiovascular disease, yet its association with left …
lipoprotein (a)[Lp (a)] and atherosclerotic cardiovascular disease, yet its association with left …
The nonlinear correlation between lipoprotein (a) and the prevalence of aortic valve calcification in patients with new-onset acute myocardial infarction
Z Wang, M Li, N Liu - Acta Cardiologica, 2022 - Taylor & Francis
Background Growing studies show that lipoprotein (a)[Lp (a)] is related to calcified aortic
valve diseases in general population, while the relationship between Lp (a) and aortic valve …
valve diseases in general population, while the relationship between Lp (a) and aortic valve …
Lipoprotein Assessment in the twenty-first Century
Lipoproteins are a heterogeneous and polydisperse group of particles that transport water-
insoluble lipids like cholesterol in plasma. Extensive research over more than 6 decades …
insoluble lipids like cholesterol in plasma. Extensive research over more than 6 decades …
Perspective Chapter: Lipoprotein (a), Cardiac Amyloidosis, and Aortic Stenosis-Underestimated Associations
G Santangelo, N Bernardi, A Faggiano… - Aortic Stenosis-Recent …, 2022 - air.unimi.it
This chapter aims to address two peculiar aspects of pathophysiology and clinical
management of aortic valve stenosis, such as coexistence with cardiac amyloidosis and …
management of aortic valve stenosis, such as coexistence with cardiac amyloidosis and …